Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
443 studies found for:    Open Studies | "Hormones"
Show Display Options
Rank Status Study
1 Recruiting Clinical Study of Pegylated Somatropin to Treat Children Growth Hormone Deficiency
Condition: Growth Hormone Deficiency
Intervention: Drug: PEG-somatropin
2 Recruiting A Study of Enzalutamide Plus Androgen Deprivation Therapy (ADT) Versus Placebo Plus ADT in Patients With Metastatic Hormone Sensitive Prostate Cancer (mHSPC)
Condition: Metastatic Hormone Sensitive Prostate Cancer
Interventions: Drug: Enzalutamide;   Drug: Placebo
3 Recruiting Pegylated Somatropin (PEG Somatropin) in the Treatment of Children With Growth Hormone Deficiency
Condition: Growth Hormone Deficiency
Intervention: Biological: Jintropin AQ
4 Not yet recruiting Safety and Efficacy Phase 3 Study of Long-acting hGH (MOD-4023) in Growth Hormone Deficient Children
Condition: Pediatric Growth Hormone Deficiency
Interventions: Drug: MOD-4023;   Drug: Somatropin
5 Recruiting Investigating Efficacy and Safety of Once-weekly NNC0195-0092 Treatment Compared to Daily Growth Hormone Treatment (Norditropin® FlexPro®) in Growth Hormone Treatment naïve Pre-pubertal Children With Growth Hormone Deficiency
Conditions: Growth Hormone Disorder;   Growth Hormone Deficiency in Children
Interventions: Drug: NNC0195-0092;   Drug: Norditropin® FlexPro® pen
6 Recruiting A Phase Ib Dose Escalation Study of the Combination of LEE011 With Letrozole and Dose Expansion of LEE011 With Hormonal Therapy for the Treatment of Pre-(With Goserelin) and Postmenopausal Women With Hormone Receptor Positive, HER2-negative, Advanced Breast Cancer
Condition: Hormone Receptor Positive, HER2-negative, Advanced Breast Cancer
Interventions: Drug: LEE011;   Drug: Letrozole;   Drug: Tamoxifen;   Drug: Fulvestrant;   Drug: goserelin
7 Recruiting Medico-economic Interest of Taking Into Account Circulating Tumor Cells (CTC) to Determine the Kind of First Line Treatment for Metastatic, Hormone-receptors Positive, Breast Cancers
Conditions: Ductal Infiltrating Metastatic Breast Cancer;   Hormone-receptors Positive Breast Cancer
Intervention: Biological: Circulating tumor cells counting at baseline
8 Recruiting Neoadjuvant Response-guided Treatment of Slowly Proliferating Hormone Receptor Positive Tumors
Conditions: Early-Stage Breast Carcinoma;   Hormone Receptor Positive Tumor
Interventions: Drug: Tamoxifen or Aromatase Inhibitor or Aromatase Inhibitor + goserelin;   Drug: Palbociclib
9 Recruiting Versartis Trial in Pre-pubertal Japanese Children With Growth Hormone Deficiency (GHD) to Assess Long-Acting Growth Hormone (Somavaratan, VRS-317)
Conditions: Pediatric Growth Hormone Deficiency;   Growth Disorders
Intervention: Drug: Somavaratan (VRS-317)
10 Recruiting Phase IV Clinical Study of Pegylated Somatropin (PEG Somatropin) to Treat Growth Hormone Deficiency Children (Clinical Trial I)
Condition: Growth Hormone Deficiency
Intervention: Biological: PEG-somatropin
11 Recruiting A Post-Marketing Open-Label Study of the Efficacy and Immunogenicity of Somatropin (Ribosomal Deoxyribonucleic Acid [rDNA] Origin) (Nutropin AQ®) in Children With Growth Hormone Deficiency
Condition: Growth Hormone Deficiency
Intervention: Drug: Somatropin
12 Recruiting A Prospective Non-Interventional Study Protocol With Primary Data Collection - Assessment Of The Long Term Treatment Outcomes Of Genotropin Treatment In Growth Hormone Deficiency (GHD) Patients
Condition: Growth Hormone Deficiency
Intervention: Other: Non Interventional Study
13 Recruiting Versartis Long-Term Safety Study of Somavaratan
Condition: Pediatric Growth Hormone Deficiency
Intervention: Drug: somavaratan
14 Recruiting Open-label Extension Study to Evaluate the Safety of Long-term Twice-monthly Administration of Somavaratan in AGHD
Condition: Adult Growth Hormone Deficiency (AGHD)
Intervention: Drug: somavaratan
15 Recruiting Free Fatty Acids, Body Weight, and Growth Hormones Secretion in Children
Conditions: Obesity;   Short Stature;   Growth Hormone Deficiency
Interventions: Drug: Niacin;   Drug: Placebo
16 Recruiting Palbociclib / Letrozole in African American Women With HR+ HER2- Breast Cancer
Condition: Hormone Receptor Positive HER-2 Negative Breast Cancer
Intervention: Drug: Palbociclib + Letrozole
17 Recruiting The Impact of the Use of Recombinant Human Growth Hormone on ADHD Characteristics in Children and Adolescents
Conditions: Growth Hormone Deficiency;   Attention Deficit Disorder;   Idiopathic Short Stature
Intervention: Other: Questionnaires
18 Recruiting Hormone Receptor Positive endometrIal Carcinoma Treated by Dual mTORC1/mTORC2 Inhibitor and Anastrozole (VICTORIA)
Conditions: Endometrial Carcinoma;   Metastatic Carcinoma;   Hormone Receptor Positive Tumor
Interventions: Drug: AZD2014;   Drug: Anastrozole
19 Recruiting Endoxifen in Adults With Hormone Receptor Positive Solid Tumors
Conditions: Hormone Receptor-Positive Breast;   Gynecologic;   Desmoid;   Hormone Receptor-Positive Neoplasms
Intervention: Drug: Z-Endoxifen
20 Recruiting The Effect of Medical Clown on the Pain and Anxiety Perception During LRH Analog Treatment or GH Provocation Test
Conditions: Precocious Puberty;   Growth Hormone Tests
Intervention: Behavioral: Presence of medical clown during endocrine test

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.